GenScript Peptides: difference between revisions
Diff·revision 5 → 6·06:15, 21 Sep 2025
Difference between revision 5 and revision 6 of GenScript Peptides. 9 lines changed; the page grew by 2,136 bytes.
| Revision 5 — 05:14, 17 Sep 2025 ChainCustodyChad (talk) attribute the documentation description to the purchaser reports it comes from 4,213 bytes +229 | Revision 6 — 06:15, 21 Sep 2025 ShortageShona (talk) add the incorporation year, attributed to the registry record 6,349 bytes +2,136 | ||
|---|---|---|---|
| 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} | 10 | The organisation is one of twenty-eight covered on PeptidePedia under [[Project:Vendor notability]]. Like the others, it distributes material labelled [[Research use only|for research use only]], which is '''not approved for human use''' in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.{{r|ruo}} |
| 11 | 11 | ||
| + | 12 | This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by [[Janoshik Analytical]], [[Medutest]], [[PeptideMeter]] and [[VendorInvestigate]].{{r|tally}} | |
| + | 13 | ||
| 12 | == Corporate identity and history == | 14 | == Corporate identity and history == |
| 13 | Incorporated in Nanjing in 2002, the organisation sits with the earlier incorporation dates among the entities covered on this wiki and predates the current research-peptide market by roughly a decade.{{r|registry}} Nanjing is inside the Yangtze River Delta manufacturing belt, and the organisation's own material describes a business built on [[Solid-phase peptide synthesis|solid-phase synthesis]] and custom sequence work rather than on catalogue distribution alone.{{r|selfpub}} | 15 | Incorporated in Nanjing in 2002, the organisation sits with the earlier incorporation dates among the entities covered on this wiki and predates the current research-peptide market by roughly a decade.{{r|registry}} Nanjing is inside the Yangtze River Delta manufacturing belt, and the organisation's own material describes a business built on [[Solid-phase peptide synthesis|solid-phase synthesis]] and custom sequence work rather than on catalogue distribution alone.{{r|selfpub}} |
| ⋮ | ⋮ | ||
| 20 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 22 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| 21 | 23 | ||
| + | 24 | == Operations and documentation practice == | |
| + | 25 | Purchaser reports describe vialled lyophilised material arriving with a batch-specific [[Certificate of analysis|certificate]] naming a [[Batch number|lot]], and across the submitted set the lot string on the certificate has corresponded to the vial label.{{r|reports}} That correspondence is a minimum requirement rather than an achievement, and it is recorded only because [[Lot traceability|traceability]] fails often enough elsewhere in this sector to make its absence the more common finding. | |
| + | 26 | ||
| + | 27 | Water content by [[Karl Fischer titration|Karl Fischer titration]] appears on the certificates described in the submitted set, and [[Peptide content|peptide content]] is reported on a separate line from chromatographic purity across a substantial part of it.{{r|reports,usp1503}} Those two determinations are what let a purity percentage be read as a statement about mass, and their routine presence is the most useful documentary observation available about this organisation. The column, the gradient and the detection wavelength are described as printed on the document rather than supplied on request, which makes the separation reproducible in principle by a reader with access to the instrument.{{r|reports}} | |
| + | 28 | ||
| 22 | == References == | 29 | == References == |
| 23 | {{reflist}} | 30 | {{reflist}} |
| ⋮ | ⋮ | ||
| 25 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> | 32 | <ref name="selfpub">Organisation's own published product and company documentation, retrieved 2026. Self-published primary source: usable for what the organisation states about itself and for nothing else, per [[Project:Verifiability]].</ref> |
| 26 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 33 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| + | 34 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | |
| + | 35 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 27 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 36 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 28 | 37 |